113 related articles for article (PubMed ID: 15584965)
1. B-Lymphocytes activated by CD40 ligand induce an antigen-specific anti-tumour immune response by direct and indirect activation of CD8(+) T-cells.
Ritchie DS; Yang J; Hermans IF; Ronchese F
Scand J Immunol; 2004 Dec; 60(6):543-51. PubMed ID: 15584965
[TBL] [Abstract][Full Text] [Related]
2. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
[TBL] [Abstract][Full Text] [Related]
3. Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients.
Davis ID; Chen Q; Morris L; Quirk J; Stanley M; Tavarnesi ML; Parente P; Cavicchiolo T; Hopkins W; Jackson H; Dimopoulos N; Tai TY; MacGregor D; Browning J; Svobodova S; Caron D; Maraskovsky E; Old LJ; Chen W; Cebon J
J Immunother; 2006; 29(5):499-511. PubMed ID: 16971806
[TBL] [Abstract][Full Text] [Related]
4. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC.
Ivanov R; Aarts T; Hagenbeek A; Hol S; Ebeling S
Cytotherapy; 2005; 7(1):62-73. PubMed ID: 16040385
[TBL] [Abstract][Full Text] [Related]
5. Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis.
Harp CT; Lovett-Racke AE; Racke MK; Frohman EM; Monson NL
Clin Immunol; 2008 Sep; 128(3):382-91. PubMed ID: 18599355
[TBL] [Abstract][Full Text] [Related]
6. B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner.
Rodríguez-Pinto D; Moreno J
Eur J Immunol; 2005 Apr; 35(4):1097-105. PubMed ID: 15756646
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
Robson NC; Donachie AM; Mowat AM
Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
[TBL] [Abstract][Full Text] [Related]
8. RNA-electroporated CD40-activated B cells induce functional T-cell responses against HepG2 cells.
Shen SN; Xu Z; Qian XP; Ding YT; Yu LX; Liu BR
Eur J Cancer Care (Engl); 2008 Jul; 17(4):404-11. PubMed ID: 18485013
[TBL] [Abstract][Full Text] [Related]
9. Lentivector immunization induces tumor antigen-specific B and T cell responses in vivo.
Garcia Casado J; Janda J; Wei J; Chapatte L; Colombetti S; Alves P; Ritter G; Ayyoub M; Valmori D; Chen W; Lévy F
Eur J Immunol; 2008 Jul; 38(7):1867-76. PubMed ID: 18546142
[TBL] [Abstract][Full Text] [Related]
10. The immunogenicity of dendritic cell-derived exosomes.
Quah BJ; O'Neill HC
Blood Cells Mol Dis; 2005; 35(2):94-110. PubMed ID: 15975838
[TBL] [Abstract][Full Text] [Related]
11. [Establishment of long-term culture system for human B cells derived from peripheral blood mononuclear cells activated via soluble CD40 ligand].
Wu C; Liu Y; Zhao Q; Chen GM; Chen JH; Yan XM; Zhou YH; Huang ZH
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):124-7. PubMed ID: 19489277
[TBL] [Abstract][Full Text] [Related]
12. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
13. Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell immunity in vitro via amplification of T-cell help.
Decker WK; Xing D; Li S; Robinson SN; Yang H; Yao X; Segall H; McMannis JD; Komanduri KV; Champlin RE; Shpall EJ
Vaccine; 2006 Apr; 24(16):3203-16. PubMed ID: 16480795
[TBL] [Abstract][Full Text] [Related]
14. Activation of B cells using Schneider 2 cells expressing CD40 ligand for the enhancement of antigen presentation in vitro.
Yoon SH; Cho HI; Kim TG
Exp Mol Med; 2005 Dec; 37(6):567-74. PubMed ID: 16391518
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of CD40L and CD70 by semiallogenic tumor cells induces anti-tumor immunity.
Cormary C; Hiver E; Mariamé B; Favre G; Tilkin-Mariamé AF
Cancer Gene Ther; 2005 Dec; 12(12):963-72. PubMed ID: 15956983
[TBL] [Abstract][Full Text] [Related]
16. IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens.
Lapenta C; Santini SM; Spada M; Donati S; Urbani F; Accapezzato D; Franceschini D; Andreotti M; Barnaba V; Belardelli F
Eur J Immunol; 2006 Aug; 36(8):2046-60. PubMed ID: 16856207
[TBL] [Abstract][Full Text] [Related]
17. RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma.
Mason NJ; Coughlin CM; Overley B; Cohen JN; Mitchell EL; Colligon TA; Clifford CA; Zurbriggen A; Sorenmo KU; Vonderheide RH
Gene Ther; 2008 Jul; 15(13):955-65. PubMed ID: 18337841
[TBL] [Abstract][Full Text] [Related]
18. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
Kleindienst P; Brocker T
Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
[TBL] [Abstract][Full Text] [Related]
19. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
[TBL] [Abstract][Full Text] [Related]
20. Activated B cells mediate efficient expansion of rare antigen-specific T cells.
Zentz C; Wiesner M; Man S; Frankenberger B; Wollenberg B; Hillemanns P; Zeidler R; Hammerschmidt W; Moosmann A
Hum Immunol; 2007 Feb; 68(2):75-85. PubMed ID: 17321896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]